RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

Robert F. Kennedy Jr., Trump’s pick to be health secretary, is keeping his financial stake in major vaccine litigation ...

Molecular subunits link to produce polymer chains that can connect through their backbones and cross-linked molecules to form ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics ...

Mar. 6, 2024 — 'Random DNA' is naturally active in the one-celled ... artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...